Terms: = Thyroid cancer AND PDGFRA, MGC74795, 5156, ENSG00000134853, PDGFR2, CD140A, Rhe-PDGFRA, CD140a, P16234 AND Treatment
6 results:
1. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary thyroid Carcinoma in a Colombian Cohort.
Cruz-Romero SD; González S; Juez JY; Becerra DS; Baldión AM; Hakim JA; González-Devia D; Perdomo S; Rodríguez-Urrego PA
Adv Ther; 2024 Feb; 41(2):792-805. PubMed ID: 38170436
[TBL] [Abstract] [Full Text] [Related]
2. Integrated Bioinformatics Analysis of DNA Methylation Biomarkers in thyroid cancer Based on TCGA Database.
Zhao L; Jia Y; Liu Y; Han B; Wang J; Jiang X
Biochem Genet; 2022 Apr; 60(2):629-639. PubMed ID: 34387764
[TBL] [Abstract] [Full Text] [Related]
3. Using Ion Torrent sequencing to study genetic mutation profiles of fatal thyroid cancers.
Lu JY; Cheng WC; Chen KY; Lin CC; Chang CC; Kuo KT; Chen PL
J Formos Med Assoc; 2018 Jun; 117(6):488-496. PubMed ID: 28757314
[TBL] [Abstract] [Full Text] [Related]
4. NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma.
Tiedje V; Ting S; Herold T; Synoracki S; Latteyer S; Moeller LC; Zwanziger D; Stuschke M; Fuehrer D; Schmid KW
Oncotarget; 2017 Jun; 8(26):42613-42620. PubMed ID: 28489587
[TBL] [Abstract] [Full Text] [Related]
5. Identification of Differentially Expressed Kinase and Screening Potential Anticancer Drugs in Papillary thyroid Carcinoma.
Zhang H; Gao B; Shi B
Dis Markers; 2016; 2016():2832980. PubMed ID: 27703281
[No Abstract] [Full Text] [Related]
6. RET mutation and increased angiogenesis in medullary thyroid carcinomas.
Verrienti A; Tallini G; Colato C; Boichard A; Checquolo S; Pecce V; Sponziello M; Rosignolo F; de Biase D; Rhoden K; Casadei GP; Russo D; Visani M; Acquaviva G; Ferdeghini M; Filetti S; Durante C
Endocr Relat Cancer; 2016 Aug; 23(8):665-76. PubMed ID: 27402614
[TBL] [Abstract] [Full Text] [Related]
